Posts Tagged 222

Yanking the Cure Rug Out From Under Lymphoma Patients

In the continuing saga of two “miracle” drugs for those who suffer from non-Hodgkins lymphomas… the fifth most common cancer…. I told you six months ago about Bexxar and Zevalin, the two drugs which can treat non-Hodgkins lymphoma but were not being promoted by oncologists in private practice because they cannot, by law, administer it. […]

Continue Reading →

Posted in: Health /Medical Consumerism, Health Insurance, Healthcare Quality, Hospitals, Patient Empowerment, Pharmaceutical Drugs

Leave a Comment (0) →